Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
Cash from Investing Activities
Fusion Antibodies PLC
Cash from Investing Activities Peer Comparison
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fusion Antibodies PLC
LSE:FAB
|
Cash from Investing Activities
£248k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Cash from Investing Activities
-£61.8m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Cash from Investing Activities
-£1.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Cash from Investing Activities
-£4.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-76%
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Cash from Investing Activities
-£2.4m
|
CAGR 3-Years
37%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Cash from Investing Activities
-£5.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-125%
|
CAGR 10-Years
-54%
|
See Also
What is Fusion Antibodies PLC's Cash from Investing Activities?
Cash from Investing Activities
248k
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Cash from Investing Activities amounts to 248k GBP.